U.S. Software Stock News

In recent weeks, H.C. Wainwright reaffirmed a positive outlook on Gossamer Bio after its lead pulmonary arterial hypertension drug, seralutinib, delivered encouraging long-term results in the Phase 2 TORREY trial and drew optimism ahead of Phase 3 PROSERA data. This momentum has been further supported by promising FDA designations and Gossamer Bio’s active engagement in conferences, reflecting both industry attention and renewed interest in innovative lung disease treatments. We'll examine...

Wondering what to do with Evolent Health stock after a wild ride in the market? You are not alone. The stock has turned heads in both directions lately, with a 6.7% dip over the past week and a 3% slip over the past month. If you have held on through the past year, it has been especially challenging, given a staggering 70.3% drop over that period. Even the longer-term returns, down 76.4% for three years and 21.6% over five years, may have shaken the confidence of even the most steadfast...

Key Insights Veralto's estimated fair value is US$135 based on 2 Stage Free Cash Flow to Equity Veralto's US$109 share...

Big Tree Cloud Holdings (NasdaqGM:DSY) has suddenly captured attention after a massive jump in its stock value last week, with shares rising 172%. What has everyone talking is not just the rally itself, but the fact that insiders, especially CEO Wenquan Zhu, who owns a striking 88% of the company, have been the primary beneficiaries of this move. Minimal institutional involvement and scant analyst coverage mean this surge feels very much driven by those closest to the business, rather than...

If you have been watching Mineralys Therapeutics lately, you are probably wondering just how much more it can deliver for your portfolio. The buzz is real, and so are the numbers. With a 155.5% surge over the past 30 days and a staggering 202.9% gain so far this year, Mineralys has certainly gotten investors’ attention. Its one-year return of 219.8% stands out not just in its sector, but across the broader market as well. Part of this momentum can be traced to growing optimism around...

We wouldn't blame Lazard, Inc. ( NYSE:LAZ ) shareholders if they were a little worried about the fact that Evan Russo...

RLX Technology's (NYSE:RLX) stock is up by a considerable 23% over the past month. However, we decided to pay attention...

With a price-to-earnings (or "P/E") ratio of 16.7x Abbott Laboratories ( NYSE:ABT ) may be sending bullish signals at...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Haemonetics fair value estimate is US$100 Haemonetics...

As the U.S. stock market navigates a landscape of mixed signals, with the Nasdaq reaching new heights while inflation data and interest rate expectations loom large, small-cap stocks are attracting attention for their potential resilience and growth opportunities. In such a climate, identifying promising small-cap companies involves looking at factors like insider buying trends and regional diversification, which can offer valuable insights into a company's perceived value and future prospects.

As the U.S. market navigates a landscape marked by mixed performances in major indices and anticipation of interest rate cuts from the Federal Reserve, small-cap stocks present intriguing opportunities for investors looking beyond the headline-grabbing tech giants. In this environment, identifying stocks with solid foundations—such as strong financial health, innovative products, or robust growth potential—can be key to uncovering hidden gems like NetScout Systems and other promising...

As the U.S. stock market navigates a mixed landscape with the Nasdaq reaching record highs while the Dow slips, investors are closely watching for potential interest rate cuts from the Federal Reserve that could bolster an uncertain labor market. In this dynamic environment, dividend stocks remain a compelling option for those seeking steady income, offering resilience and potential stability amid fluctuating economic conditions.

If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see...

We'd be surprised if LifeMD, Inc. ( NASDAQ:LFMD ) shareholders haven't noticed that the Chief Acquisition Officer...

Wearable Devices ( NASDAQ:WLDS ) First Half 2025 Results Key Financial Results Revenue: US$294.0k (down 25% from 1H...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

From what we can see, insiders were net sellers in Brown & Brown, Inc.'s ( NYSE:BRO ) during the past 12 months. That...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Gentex fair value estimate is US$40.24 Gentex is estimated to...

It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...

It is hard to get excited after looking at JX Luxventure Group's (NASDAQ:JXG) recent performance, when its stock has...

Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. While...

Most readers would already know that Snap-on's (NYSE:SNA) stock increased by 8.6% over the past three months. Given its...

Northeast Bank ( NASDAQ:NBN ) Full Year 2025 Results Key Financial Results Revenue: US$204.1m (up 34% from FY 2024...